UROLOGIC CANCER
Clinical trials for UROLOGIC CANCER explained in plain language.
Never miss a new study
Get alerted when new UROLOGIC CANCER trials appear
Sign up with your email to follow new studies for UROLOGIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Withdrawn trial aimed to stop bladder Cancer's return
Disease control TerminatedThis study planned to test whether a new drug called NDV-01 could help prevent cancer from coming back in people with intermediate-risk, non-muscle invasive bladder cancer. Participants would have had their tumors removed and then been randomly assigned to either receive the drug…
Matched conditions: UROLOGIC CANCER
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Withdrawn trial aimed to save bladders from cancer surgery
Disease control TerminatedThis study planned to test a new bladder cancer treatment called NDV-01 for patients whose cancer returned after standard therapies. The treatment would have been delivered directly into the bladder to try to control the cancer and potentially avoid major surgery. However, the tr…
Matched conditions: UROLOGIC CANCER
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New bladder cancer therapy aims to stop recurrence after surgery
Disease control OngoingThis study is testing a new treatment called cretostimogene to see if it can prevent intermediate-risk bladder cancer from returning after tumor removal surgery. About 367 participants will be randomly assigned to receive either the new treatment or standard observation with regu…
Matched conditions: UROLOGIC CANCER
Phase: PHASE3 • Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC